Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes

Jennifer G. Le-Rademacher, Camden L. Lopez, Rahul Kanwar, Brittny Major-Elechi, Alexej Abyzov, Michaela S. Banck, Terry M. Therneau, Jeff A. Sloan, Charles L. Loprinzi, Andreas S. Beutler

Original languageEnglish (US)
Article number116687
JournalJournal of the neurological sciences
Volume411
DOIs
StatePublished - Apr 15 2020

    Fingerprint

Keywords

  • Charcot-Marie-tooth disease
  • Chemotherapy
  • Hereditary
  • Neuropathy
  • Oxaliplatin
  • Risk factors

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this